Use of hydrazine sulphate in the treatment of brain tumours

Use of hydrazine sulphate in the treatment of brain tumours

The invention relates to a new use of hydrazine sulphate characterized in that hydrazine sulphate is used in the treatment of brain tumours. Administration is preferably by the oral route at a dose which is preferably 0.18 g/day in the adult and 0.09 g/day in the child. The treatment involves cycles...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DANOVA LIDIA A, IVIN BORIS A, GERSHANOVICH MICHAEL L, KRAIZ BORIS O, FILOV VLADIMIR A, STUKOV ALEXANDER N
Format: Patent
Sprache:eng ; ita
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a new use of hydrazine sulphate characterized in that hydrazine sulphate is used in the treatment of brain tumours. Administration is preferably by the oral route at a dose which is preferably 0.18 g/day in the adult and 0.09 g/day in the child. The treatment involves cycles variable from 30 to 40 days, repeatable at variable intervals from 2 to 4 weeks or from 2 to 5 months.